ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,601,549 | +33.2% | 253,069 | 0.0% | 0.43% | +12.1% |
Q1 2023 | $1,953,693 | +5.0% | 253,069 | 0.0% | 0.38% | +16.2% |
Q4 2022 | $1,860,057 | +1.5% | 253,069 | -0.6% | 0.33% | -40.4% |
Q3 2022 | $1,833,000 | -62.8% | 254,569 | -56.0% | 0.55% | -73.7% |
Q2 2022 | $4,921,000 | -47.0% | 578,260 | -44.1% | 2.09% | -43.9% |
Q1 2022 | $9,277,000 | -42.8% | 1,034,222 | -11.6% | 3.72% | -50.9% |
Q4 2021 | $16,207,000 | – | 1,170,212 | – | 7.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |